Authors

  • Ya. Nadjimitdinov
    Tashkent Medical Academy
  • T. Akhmadaliev
  • S. Khusanov

DOI:

https://doi.org/10.71337/inlibrary.uz.ijms.76170

Abstract

From 2020 to 2024, transurethral resection of the prostate was performed in 124 men with benign prostatic hyperplasia, the average age of patients was 67.8 ± 6.1 years. The volume of adenoma before surgery was 94.25 ± 2.83 ml3. The overall complication rate was 19.4%. Additional interventions after adenoma removal were performed in 4 (3.2%) men due to bleeding from the prostate bed (vascular coagulation) and bladder neck sclerosis (transurethral resection).

 

 

background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

M

ar

ch

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

UDC 616.65-007.61-089.85-06-036-07

ASSESSMENT OF COMPLICATIONS OF TRANSURETHRAL RESECTION OF

THE PROSTATE USING THE CLAVIEN-DINDO CLASSIFICATION

Nadjimitdinov Ya.S.,

Associate Professor, PhD, Department of Urology, Tashkent Medical Academy

Akhmadaliev T.G.,

Master's student of the Department of Urology, Tashkent Medical Academy

Khusanov S.M.

Urologist

Abstract:

From 2020 to 2024, transurethral resection of the prostate was performed in 124

men with benign prostatic hyperplasia, the average age of patients was 67.8 ± 6.1 years. The

volume of adenoma before surgery was 94.25 ± 2.83 ml3. The overall complication rate was

19.4%. Additional interventions after adenoma removal were performed in 4 (3.2%) men

due to bleeding from the prostate bed (vascular coagulation) and bladder neck sclerosis

(transurethral resection).

Keywords:

Clavien-Dindo, complications, transurethral resection of the prostate

ОЦЕНКА ОСЛОЖНЕНИЙ ТРАНСУРЕТРАЛЬНОЙ РЕЗЕКЦИИ ПРОСТАТЫ С

ИСПОЛЬЗОВАНИЕМ КЛАССИФИКАЦИИ CLAVIEN-DINDO

Аннотация:

За период с 2020 по 2024 года выполнена трансуретральная резекция

простаты 124 мужчинам с доброкачественной гиперплазией простаты, средний

возраст пациентов был 67,8± 6,1 лет. Объем аденомы до операции составил 94,25±2,83

мл3. Общая частота осложнений составила 19,4%. Дополнительные вмешательства

после удаления аденомы выполнены у 4 (3,2%) мужчин в связи с кровотечением из

ложа простаты (коагуляция сосудов) и склероза шейки мочевого пузыря

(трансуретральная резекция).

Ключевые слова:

Clavien- Dindo, осложнения, трансуретральная резекция простаты.

Introduction

According to the European Association of Urology (EAU), benign prostatic hyperplasia

(BPH) is one of the most common diseases in elderly men [1]. After the age of 50, BPH is

diagnosed in 30%-40% of men, and its prevalence increases to 70%-80% in individuals over

80 years old.

Lower urinary tract symptoms (LUTS) are the main complaints in men with prostate

pathology, causing discomfort and negatively impacting quality of life. Organic infravesical


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

M

ar

ch

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

obstruction caused by BPH leads to benign neurogenic bladder dysfunction, particularly

detrusor overactivity. If left untreated for a long time, obstruction often results in

complications such as recurrent urinary tract infections (UTIs), hematuria, bladder stone

formation, and acute or chronic urinary retention [2].

Watchful waiting (careful observation) is one of the treatment options, except in patients

with BPH complications. A decrease in urinary flow rate, the presence of residual urine,

hematuria, and upper urinary tract dysfunction are absolute indications for surgical

intervention. Transurethral resection of the prostate (TURP) remains the gold standard for

treating men with a prostate volume of 30-80 cm³ [1]. Following this procedure, patients

experience improved lower urinary tract function and a corresponding improvement in

quality of life in more than 70% of cases [3].

Despite advances in innovative technologies and the use of bipolar resectoscopes, surgical

intervention is still associated with intra- and postoperative complications. Although the

mortality and postoperative complication rates have decreased in recent years, they remain

significant, ranging from 0.1% to 11.1% [4]. Therefore, an analysis of the causes and

structure of postoperative complications is necessary to prevent their occurrence in the

future.

The Clavien-Dindo classification, proposed by Clavien P.A. and Dindo D., is the most

widely used tool for systematizing postoperative complications of TURP in surgery [5].

Mamoulakis C. et al. modified this classification to assess the severity of surgical

interventions performed for prostate pathology [6].

Objective

This study aims to assess post-TURP complications based on the Clavien-Dindo

classification, performed in a private clinic setting.

Materials and Methods

A retrospective analysis was conducted on 124 men with BPH who underwent TURP

between January 2020 and December 2024.

The mean age of the patients was 67.8±6.1 years (range: 57 to 80 years).

Preoperative assessments included:

Clinical and laboratory tests of blood and urine

Measurement of prostate-specific antigen (PSA) levels

Evaluation of LUTS severity using the International Prostate Symptom Score (IPSS)

Uroflowmetry to determine lower urinary tract dysfunction


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

M

ar

ch

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

The surgical procedure was performed using a bipolar resectoscope (26Fr, Karl Storz,

Germany) following a standard technique.

A urethral catheter was inserted postoperatively and removed 2-3 days after surgery.

Patients were monitored for 90 days postoperatively.

To determine complications based on the Clavien-Dindo classification, we developed the

concept of “standard” postoperative course.

Criteria for a "standard" postoperative course:

Slight hematuria in urine flowing through the urethral catheter or cystostomy drainage is

allowed, but without blood clots or a decrease in serum hemoglobin levels.

Criteria for a "standard" postoperative course (continued):

Subfebrile fever or hyperthermia above 38°C, without chills, of short duration (no more than

one day) and easily controlled with antipyretics, without clinical or laboratory signs of

pyelonephritis exacerbation or sepsis.

Absence of inflammatory complications in scrotal organs.

No drainage dysfunction that leads to bladder emptying disorders or an increase in serum

creatinine due to upper urinary tract dysfunction.

Statistical Analysis

Simple descriptive statistics were performed using IBM SPSS Statistics for Windows,

version 20.0.

Results

Mean prostate/adenoma volume before surgery, measured by transrectal sonography:

94.25±2.83 cm³

Mean weight of removed tissue during TURP: 84.25±4.22 g

Mean duration of the surgical procedure: 74.53±6.80 min

Mean hospital stay: 4.38±1.19 days

A total of 24 patients (19.4%) experienced complications after TURP, deviating from the

standard postoperative course (see table).

Five patients (I degree) required increased urethral catheter tension due to hematuria,

without blood clots or drainage dysfunction.


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

M

ar

ch

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

In two of these patients, catheter replacement and blood transfusion were additionally

performed (II degree).

Five patients (4.0%) developed urinary tract infections (UTIs) (I degree), confirmed by

clinical and laboratory data.

Two patients (1.6%) developed acute orchiepididymitis (I degree).

Enhanced antibacterial therapy successfully managed the infectious-inflammatory

complications of TURP.

Two patients (2.4%) experienced urinary incontinence, treated with a comprehensive

approach including anticholinergics, nonsteroidal anti-inflammatory drugs (NSAIDs), and

physiotherapy (II degree).

Two patients (4.4%) developed postoperative bleeding from the adenoma bed, leading to

blood clot formation in the bladder and tamponade (IIIb degree).

These patients underwent coagulation of bleeding vessels, blood transfusion, and

subsequently had no further bleeding episodes.

Table.

Complications of TURP from the perspective of the modified classification Clavien-

Dindo (n=124).

Degree

Complication

Therapy

Number

of

patients (%)

I

Intense blood staining of urine

through catheter

Acute pyelonephritis

Acute orchiepididymitis

Infusion

therapy,

increasing

catheter

tension

Correction

of

antibacterial therapy

5 (4,0)

5 (4,0)

2 (1,6)

II

Bleeding from the bed of the

removed prostate, impaired

drainage function due to blood

clots

Urinary incontinence

Blood

transfusion,

bedside

catheter

replacement

Cholinolytics,

physiotherapy

2 (4,4%)


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

M

ar

ch

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

3 (2,4)

IIIb

Bleeding from the bed of the

removed

prostate,

bladder

tamponade

Postoperative sclerosis of the

neck of the bladder

Cystoscopy, coagulation

of bleeding vessels of the

bed of the removed

adenoma

TUR of sclerosis

2 (1,6)

2 (1,6)

IVb

TUR syndrome

Treatment in the intensive

care

unit

(diuretics,

infusion therapy)

3(2,4)

Total

24 (19,4)

Syndrome after Transurethral Resection of the Prostate (TURP)

The syndrome after TURP was observed in three patients (2.4%), who were transferred to

the intensive care unit for appropriate treatment. After therapy, the patients were moved

back to the ward, the urethral catheter was removed, and the rehabilitation period proceeded

without complications. After 4 months, two patients developed bladder neck sclerosis, as

shown by urethrogram, and they underwent TURP of the narrowed section, with subsequent

good results.

Discussion

In our study, the incidence of postoperative complications was 24.74%, which is consistent

with the results of other authors who used the Clavien-Dindo classification of complications

(9.1%-34.4%) [7].

Agrawal M. et al. identified 9.1% complications after TURP, a lower rate than in our study

[8]. This difference is attributed to the fact that patients with urinary incontinence were

treated by a general practitioner. Bladder neck stricture typically develops after three to four

months following TURP, whereas the authors observed patients for only two months.

According to Mamoulakis C. et al. [6], the overall complication rate was 15.7%, though

more patients had urethral catheters before the operation (70.1%) compared to our study

(19.7%). Additionally, the average prostate size before surgery in our study was larger than

in the study by these authors (94.25±2.83 cm³ vs 80.88±12.02 cm³, p<0.004). These factors

are thought to negatively affect the complication rates.

The overall complication rate reported by Agrawal M. et al. was 34.4%, which is higher than

the rate in our study [7]. However, it is notable that these authors considered transitory

postoperative hematuria as a complication. We believe that hematuria that does not require


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

M

ar

ch

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

medical treatment occurs in all patients after TURP and should not be classified as a

complication unless it necessitates blood transfusion or interventions for clot evacuation

and/or vascular coagulation. Additionally, urethral catheter dysfunction due to blood clots

should not be regarded as a complication, as this is usually resolved by flushing the catheter.

Stress urinary incontinence was observed in three patients (2.4%). One patient regained

bladder control after 6 months, while the other two showed significant improvement, though

some degree of stress incontinence persisted.

Bladder neck sclerosis developed in two patients (4.4%), who underwent TURP of the

sclerosis tissue. After this procedure, their urination became satisfactory. Some authors

report the incidence of bladder neck sclerosis or posterior urethral stricture as 2.2%-9.8%

[4,5]. In our study, the incidence of bladder neck sclerosis was lower due to the use of a

resectoscope with continuous irrigation flow, which avoids the need for frequent instrument

removal to decompress the bladder, as well as the larger prostate/adenoma volume.

Conclusion

TURP is an effective treatment method for patients with prostatic adenoma, associated with

minimal life-threatening complications that can be easily managed.

References

1.

Gravasa S., Gaccib M., Gratzked C., Thomas R.W. et.al. Summary paper on the 2023

european association of urology guidelines on the management of non-neurogenic male

lower urinary tract symptoms. Europeanurology. 84 (2023); р.207-222.

2.

Curtis N.J. BPH: Costs and treatment outcomes. AMJ Manag Care. 2006;12;р.141-

148.

3.

Madersbacher S., Sampson N., Culig Z. Pathophysiology of Benign Prostatic

Hyperplasia and Benign Prostatic Enlargement: A Mini-Review. Gerontology.

2019;65(5);р.458-462.

4.

Reich O., Gratzke C., Bachmann A., Seitz M., Schlenker B., Hermanek P., et al.

Morbidity, mortality and early outcome of transurethral resection of the prostate: A

prospective multicenter evaluation of 10,654 patients. J Urol. 2008;180;р.246‑249.

5.

Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a

new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of

Surgery. 2004; 240; р.205-213

6.

Mamoulakis C., Efthimiou I., Kazoulis S., Christoulakis I., Sofra F. The modified

Clavien classification system: A standardized platform for reporting complications in

transurethral resection of the prostate. World J Urol. 2011;29:р.205-210.

7.

Agrawal M., Kumar M., Pandey S., Aggarwal A., Sankhwar S. Changing profiles of

patients undergoing transurethral resection of the prostate over a decade: A single‑center

experience. Urol Ann. 2019;11;р.270‑275.

Palmisano F., Boeri L., Fontana M., Gallioli A., De Lorenzis E., Zanetti S.P., et al.

Incidence and predictors of readmission within 30 days of transurethral resection of the

prostate: A single center European experience. Sci Rep. 2018;8:р.6575-6581.

References

Gravasa S., Gaccib M., Gratzked C., Thomas R.W. et.al. Summary paper on the 2023 european association of urology guidelines on the management of non-neurogenic male lower urinary tract symptoms. Europeanurology. 84 (2023); р.207-222.

Curtis N.J. BPH: Costs and treatment outcomes. AMJ Manag Care. 2006;12;р.141-148.

Madersbacher S., Sampson N., Culig Z. Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review. Gerontology. 2019;65(5);р.458-462.

Reich O., Gratzke C., Bachmann A., Seitz M., Schlenker B., Hermanek P., et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: A prospective multicenter evaluation of 10,654 patients. J Urol. 2008;180;р.246‑249.

Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery. 2004; 240; р.205-213

Mamoulakis C., Efthimiou I., Kazoulis S., Christoulakis I., Sofra F. The modified Clavien classification system: A standardized platform for reporting complications in transurethral resection of the prostate. World J Urol. 2011;29:р.205-210.

Agrawal M., Kumar M., Pandey S., Aggarwal A., Sankhwar S. Changing profiles of patients undergoing transurethral resection of the prostate over a decade: A single‑center experience. Urol Ann. 2019;11;р.270‑275.

Palmisano F., Boeri L., Fontana M., Gallioli A., De Lorenzis E., Zanetti S.P., et al. Incidence and predictors of readmission within 30 days of transurethral resection of the prostate: A single center European experience. Sci Rep. 2018;8:р.6575-6581.

Agrawal M., Kumar M., Pandey S., Aggarwal A., Sankhwar S. Changing profiles of patients undergoing transurethral resection of the prostate over a decade: A single‑center experience. Urol Ann. 2019;11;р.270‑5.